Monoclonal antibodies for neutralizing anthrax toxin
US8309090B2 · kind B2 · utility
0Cited by
1References
8Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 3, 2009 |
| Grant date | Nov 13, 2012 |
| Priority date | — |
| Expiry date | Sep 24, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Isolated monoclonal antibodies that bind and/or neutralize anthrax protective antigen (PA) are disclosed as well as hybridomas secreting such antibodies. The invention also provides anti-PA fragments of the antibodies of the invention and recombinantly produced antibodies. Also provided are pharmaceutical compositions containing the antibodies or antibody fragments and uses and methods involving same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.